| 1 |
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
Paula R. Clemens, Vamshi K. Rao, Anne M. Connolly et al. · JAMA Neurology
Open access |
26 May 2020 |
275 |
| 2 |
Genetic tool development in marine protists: emerging model organisms for experimental cell biology
Drahomíra Faktorová et al. · Nature Methods
Open access113 authors |
6 Apr 2020 |
174 |
| 3 |
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy
Christopher R. Heier, Qing Yuan Yu, Alyson A. Fiorillo et al. · Life Science Alliance
Open access |
Feb 2019 |
90 |
| 4 |
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin‐deficient mdx mice: proof‐of‐concept study and independent validation of efficacy
Roberta Francesca Capogrosso, Paola Mantuano, Kitipong Uaesoontrachoon et al. · The FASEB Journal
Open access |
2 Nov 2017 |
61 |
| 5 |
Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation
Catherine M. Biggs et al. · JCI Insight
Open access |
21 Dec 2022 |
31 |
| 6 |
Mechanism of action and therapeutic route for a muscular dystrophy caused by a genetic defect in lipid metabolism
Mahtab Tavasoli et al. · Nature Communications
Open access |
23 Mar 2022 |
30 |
| 7 |
Tyrosine kinase-mediated axial motility of basal cells revealed by intravital imaging
Jeremy W. Roy, Bong-Ki Kim, Eric Hill et al. · Nature Communications
Open access |
12 Feb 2016 |
29 |
| 8 |
Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells
Peter P. Nghiem, Joe N. Kornegay, Kitipong Uaesoontrachoon et al. · Muscle & Nerve
Open access |
26 Jul 2017 |
18 |
| 9 |
Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice
Michael Ziemba, Molly Barkhouse, Kitipong Uaesoontrachoon et al. · PLoS ONE
Open access |
22 Feb 2021 |
14 |
| 10 |
Orthogonal Analysis of Dystrophin Protein and Mrna As A Surrogate Outcome for Drug Development
Kitipong Uaesoontrachoon et al. · Biomarkers in Medicine
Open access |
5 Aug 2019 |
13 |
| 11 |
A mouse model of inherited choline kinase β-deficiency presents with specific cardiac abnormalities and a predisposition to arrhythmia
Mahtab Tavasoli, Tiam Feridooni, Hirad A. Feridooni et al. · Journal of Biological Chemistry
Open access |
10 Feb 2022 |
11 |
| 12 |
Loss of calpain3b in Zebrafish, a Model of Limb-Girdle Muscular Dystrophy, Increases Susceptibility to Muscle Defects Due to Elevated Muscle Activity
Sergey V. Prykhozhij, Lucía Cáceres, Kevin Ban et al. · Genes
Open access |
15 Feb 2023 |
9 |
| 13 |
The effect of IL-1β inhibitor canakinumab (Ilaris®) on IL-6 production in human skeletal muscle cells
Anna Cordeiro, Fiorella Morales, Maria del Carmen Parquet et al. · PLoS ONE
Open access |
6 Mar 2025 |
8 |
| 14 |
Genome Editing in Zebrafish Using High-Fidelity Cas9 Nucleases: Choosing the Right Nuclease for the Task
Sergey V. Prykhozhij, Anna Cordeiro, Lucía Cáceres et al. · Methods in molecular biology
Book chapter |
2020 |
7 |
| 15 |
Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis
Rita Spathis, Deeva Robles Kuriplach, Sabrina Narvesen et al. · Frontiers in Immunology
Open access |
3 Mar 2025 |
6 |
| 16 |
Loss of Dnajc21 leads to cytopenia and altered nucleotide metabolism in zebrafish
Sarada Ketharnathan, Sujata Pokharel, Sergey V. Prykhozhij et al. · Leukemia
Open access |
13 Aug 2024 |
6 |
| 17 |
Mechanistic analysis of MLKL-driven cell survival
Peijia Jiang, Xiaoyang Liu, Mauricio J. Reginato et al. · Cell Death Discovery
Open access |
10 Jun 2026 |
0 |
| 18 |
Neurodevelopmental disease-causing variants in choline kinase CHKA gene couple phosphatidylcholine synthesis to oxidative stress damage and disease etiology
Mahtab Tavasoli, Mariam Alkandari, Gabriel G. Dorighello et al. · Journal of Biological Chemistry
Open access |
26 Nov 2025 |
0 |
| 19 |
High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophy
Rebecca A. Slick, Jessica R. P. Sutton, Margaret Haberman et al. · Biology Open
Open access |
19 Aug 2024 |
0 |
| 20 |
REGISTRIES AND CARE OF NEUROMUSCULAR DISORDERS
A. Mullen, Kitipong Uaesoontrachoon, Sadish Srinivassane et al. · Neuromuscular Disorders
|
5 Sep 2018 |
0 |
| 21 |
DMD CLINICAL THERAPIES II
P R Clemens, Vamshi K. Rao, Anne M. Connolly et al. · Neuromuscular Disorders
|
5 Sep 2018 |
0 |
| 22 |
Progression of a Muscular Dystrophy Due to a Genetic Defect in Membrane Synthesis is Driven by Large Changes in Neutral Lipid Metabolism
Mahtab Tavasoli, Sarah Lahire, Stanislav Sokolenko et al. · Research Square
PreprintOpen access |
19 May 2021 |
0 |
| 23 |
DMD – ANIMAL MODELS & PRECLINICAL TREATMENT
Heather Gordish‐Dressman, Kitipong Uaesoontrachoon, Alexandra MacKinnon et al. · Neuromuscular Disorders
|
28 Sep 2020 |
0 |
| 24 |
Success of preclinical drug trials using reliable and reproducible endpoints in mouse models of neuromuscular diseases
Kanneboyina Nagaraju, A. Mullen, Alexandra MacKinnon et al. · Neuromuscular Disorders
|
12 Sep 2017 |
0 |